{
    "Trade/Device Name(s)": [
        "GSP Neonatal Thyroxine (T4) kit",
        "GSP Neonatal T4 assay"
    ],
    "Submitter Information": "Wallac Oy, subsidiary of PerkinElmer",
    "510(k) Number": "K103484",
    "Predicate Device Reference 510(k) Number(s)": [
        "K943416"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "KLI"
    ],
    "Summary Letter Date": "November 24, 2010",
    "Summary Letter Received Date": "February 24, 2011",
    "Submission Date": "April 12, 2011",
    "Regulation Number(s)": [
        "21CFR862.1700"
    ],
    "Regulation Name(s)": [
        "Total thyroxine test system"
    ],
    "Analyte Class(es)": [
        "endocrine"
    ],
    "Analyte(s)": [
        "Thyroxine (T4)"
    ],
    "Specimen Type(s)": [
        "Blood dried on filter paper"
    ],
    "Specimen Container(s)": [
        "Filter paper"
    ],
    "Instrument(s)/Platform(s)": [
        "GSP instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Solid phase time-resolved fluoroimmunoassay",
        "Competitive immunoassay"
    ],
    "Methodologies": [
        "Fluorescence detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for GSP Neonatal Thyroxine (T4) kit, a fluoroimmunoassay for quantitative thyroxine screening in newborn dried blood spots using the GSP instrument.",
    "Indications for Use Summary": "Quantitative determination of human thyroxine (T4) in dried blood specimens on filter paper to aid in newborn screening for congenital hypothyroidism using the GSP instrument.",
    "fda_folder": "Clinical Chemistry"
}